Publications & Guidelines

Since 2004, the Publications Committee has been charged with developing and publishing various publications, including the SMFM Consult Series and the SMFM Clinical Guidelines series published in the American Journal of Obstetrics & Gynecology. The Publications Committee collaborates with other Societies and Colleges to develop joint publications and statements, as appropriate. The Committee plans topics, selects authors, and reviews each completed paper before it is submitted for an internal SMFM review process and then for publication.  All Committee members have filed conflict of interest statements with SMFM. Any conflicts have been resolved through a process approved by the Executive Board. To facilitate transparency in SMFM's guideline development process, a brief overview of the key stages in development is provided here. Feedback for SMFM Publications is welcome at pubs@smfm.org

Coding : Coding Tips Coding : Coding White Papers Press Publications & Guidelines Publications & Guidelines : Administrative Publications & Guidelines : Consult Series Publications & Guidelines : Endorsed Partner Pub Publications & Guidelines : Health Policy Publication Publications & Guidelines : Joint Publication Publications & Guidelines : Obstetric Care Consensus Publications & Guidelines : Public/Global Health Publications & Guidelines : SMFM Special Report Publications & Guidelines : SMFM Statement

ACOG Statement on FDA Warning on Genetic Non-Invasive Prenatal Screening Tests
ACOG Statement on FDA Warning on Genetic Non-Invasive Prenatal Screening Tests

SMFM supports the new ACOG ACOG Statement on FDA Warning on Genetic Non-Invasive Prenatal Screening Tests and continues to support existing SMFM guidance on NIPT. Original Article Continue Reading

Date posted11/13/2022


SMFM Statement: Antihypertensive therapy for mild chronic hypertension in pregnancy: The CHAP Trial
SMFM Statement: Antihypertensive therapy for mild chronic hypertension in pregnancy: The CHAP Trial

Chronic hypertension occurs in approximately 2% of pregnancies in the United States and remains a major cause of maternal and perinatal morbidity and mortality. Specifically, chronic hypertension is associated with an increased risk of preeclampsia, pulmonary edema, acute kidney injury,... Continue Reading

Date posted11/12/2022


Race in maternal-fetal medicine research- Dispelling myths and taking an accurate, antiracist approa
Race in maternal-fetal medicine research- Dispelling myths and taking an accurate, antiracist approa

Profound inequities in maternal and infant outcomes based on race exist, and the maternal-fetal medicine community has an important role in eliminating these disparities. Accurately employing race and ethnicity as social constructs within research that guides clinical practice is essential to... Continue Reading

Date posted11/11/2022


SMFM Special Statement: A critique of postpartum readmission rate as a quality metric
SMFM Special Statement: A critique of postpartum readmission rate as a quality metric

Hospital readmission is considered a core measure of quality in healthcare. Readmission soon after hospital discharge can result from suboptimal care during the index hospitalization or from inadequate systems for post discharge care. For many conditions, readmission is associated with a high rate... Continue Reading

Date posted11/10/2022


Obstetrical care, research, and education for people with diverse sexual and gender identities
Obstetrical care, research, and education for people with diverse sexual and gender identities

The Society for Maternal-Fetal Medicine seeks to ensure excellence in obstetrical outcomes for all people who desire or experience pregnancy, including people with diverse sexual and gender identities. The Society commits to the use of practices in clinical and research settings that affirm the... Continue Reading

Date posted11/9/2022


SMFM Consult #60: Management of pregnancies resulting from in vitro fertilization
SMFM Consult #60: Management of pregnancies resulting from in vitro fertilization

Abstract The use of assisted reproductive technology has increased in the United States in the past several decades. Although most of these pregnancies are uncomplicated, in vitro fertilization is associated with an increased risk for adverse perinatal outcomes primarily caused by the increased... Continue Reading

Date posted11/8/2022


SMFM Special Statement: A quality metric for evaluating timely treatment of severe hypertension
SMFM Special Statement: A quality metric for evaluating timely treatment of severe hypertension

Severe hypertension in pregnancy is a medical emergency. Although expeditious treatment within 30 to 60 minutes is recommended to reduce the risk of maternal death or severe morbidity, treatment is often delayed by >1 hour. In this statement, we propose a quality metric that facilities can use... Continue Reading

Date posted11/8/2022


ACOG-SMFM Practice Advisory: Low-Dose Aspirin to prevent Preeclampsia, Related Morbidity/Mortality
ACOG-SMFM Practice Advisory: Low-Dose Aspirin to prevent Preeclampsia, Related Morbidity/Mortality

Original Article TAGS: metabolic syndrome, cardiovascular disease, care of high-risk pregnancy, hypertension CATEGORIES: Joint Publication Continue Reading

Date posted12/23/2021


SMFM Special Statement: COVID-19 research in pregnancy: progress and potential
SMFM Special Statement: COVID-19 research in pregnancy: progress and potential

The COVID-19 global pandemic has broad implications for obstetrical care and perinatal outcomes. As we approach the 2-year mark into an unprecedented international pandemic, this review presents the progress and opportunities for research related to COVID-19 and pregnancy. Research is the basis... Continue Reading

Date posted12/22/2021


SMFM Special Statement: Beyond the scalpel: in utero fetal gene therapy and curative medicine
SMFM Special Statement: Beyond the scalpel: in utero fetal gene therapy and curative medicine

Pain is a complex phenomenon that involves more than a simple physical response to external stimuli. In maternal-fetal surgical procedures, fetal analgesia is used primarily to blunt fetal autonomic responses and minimize fetal movement. The purpose of this Consult is to review the literature on... Continue Reading

Date posted12/21/2021


SMFM Special Statement: Surgical safety checklists for cesarean delivery
SMFM Special Statement: Surgical safety checklists for cesarean delivery

The routine use of surgical safety checklists can reduce perioperative complications. Generic surgical safety checklists are insufficient for cesarean delivery because each cesarean delivery involves 2 patients (the mother and the fetus or newborn), each with separate care teams and health and... Continue Reading

Date posted12/20/2021


SMFM Fetal Anomalies Consult #4: Genitourinary anomalies
SMFM Fetal Anomalies Consult #4: Genitourinary anomalies

Abnormalities of the genitourinary system are among the most common fetal structural malformations. Such anomalies range from mild (eg, mild urinary tract dilation) to severe life-threatening anomalies (eg, bilateral renal agenesis). This consult series reviews the ultrasonographic diagnosis,... Continue Reading

Date posted12/19/2021